Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.